Sensitization of BCL-2–expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737

Overexpression of the prosurvival protein BCL-2 is common in breast cancer. Here we have explored its role as a potential therapeutic target in this disease. BCL-2, its anti-apoptotic relatives MCL-1 and BCL-XL, and the proapoptotic BH3-only ligand BIM were found to be coexpressed at relatively high...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Oakes, Samantha R., Vaillant, François, Lim, Elgene, Lee, Lily, Breslin, Kelsey, Feleppa, Frank, Deb, Siddhartha, Ritchie, Matthew E., Takano, Elena, Ward, Teresa, Fox, Stephen B., Generali, Daniele, Smyth, Gordon K., Strasser, Andreas, Huang, David C. S., Visvader, Jane E., Lindeman, Geoffrey J.
Format: Artigo
Jezik:Inglês
Izdano: National Academy of Sciences 2012
Teme:
Breast Cancer Special Feature
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286989/
https://ncbi.nlm.nih.gov/pubmed/21768359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1104778108
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items